Top California Democrats announced on Monday a $100 billion stimulus plan that would borrow money from the federal government, expand tax credits for low-income Californians and offer help for small businesses in an attempt to prop up the state’s economy as the coronavirus-induced recession drags on.
New policies announced Friday aimed at lowering drug prices under Medicare would link prices to rates paid in other countries.
The number of outright failures of U.S. small businesses in the first months of the coronavirus pandemic was comparatively modest, but the months ahead look far grimmer as cash balances dwindle, federal help expires, and the disease surges back.
Senate Republicans unveiled a roughly $1 trillion coronavirus relief package Monday, paving the way for negotiations with Democrats.
After spending a May day preparing her classroom to reopen for preschoolers, Ana Aguilar was informed that the tots would not have to wear face masks when they came back. What’s more, she had to sign a form agreeing not to sue the school if she caught COVID-19 or suffered any injury from it while working there.
The workers’ compensation line is unlikely to generate a profit this year and may not recover in 2021, an insurance industry economist said during a webcast Thursday.
A White House meeting with top pharmaceutical executives that President Donald Trump promised for Tuesday is off, five industry sources familiar with discussions told POLITICO. Three said the drug-pricing discussion was canceled because the major drug lobbies, reeling from Friday’s cluster of executive orders on the topic, refused to send any members.
If Congress doesn’t act to extend an extra $600 in weekly benefits for unemployed Californians, state legislators say they’re ready to jump in to prevent benefits from plunging during the pandemic.
Most Americans receive health insurance through their job or a family member’s job. So, when workers lose their jobs, they — and their family members — run the risk of losing their health coverage as well.
Drugmaker Pfizer on Monday became the second drugmaker to announce it had begun phase 3 testing of a vaccine to prevent the spread of coronavirus.